Is National HealthCare Stock a Good Investment?
National HealthCare Investment Advice | NHC |
- Examine National HealthCare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research National HealthCare's leadership team and their track record. Good management can help National HealthCare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact National HealthCare's business and its evolving consumer preferences.
- Compare National HealthCare's performance and market position to its competitors. Analyze how National HealthCare is positioned in terms of product offerings, innovation, and market share.
- Check if National HealthCare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about National HealthCare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in National HealthCare stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if National HealthCare is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine National HealthCare Stock
Researching National HealthCare's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 20.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.98. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. National HealthCare recorded earning per share (EPS) of 7.99. The entity last dividend was issued on the 30th of December 2024.
To determine if National HealthCare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding National HealthCare's research are outlined below:
| National HealthCare generated a negative expected return over the last 90 days | |
| National HealthCare has a strong financial position based on the latest SEC filings | |
| About 61.0% of the company shares are owned by institutional investors | |
| On 1st of November 2024 National HealthCare paid $ 0.61 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Disposition of 8000 shares by Timothy Shelly of National HealthCare at 94.1 subject to Rule 16b-3 |
National HealthCare Quarterly Cost Of Revenue |
|
National HealthCare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in National HealthCare. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to National HealthCare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 16th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
National HealthCare's market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.9 B.Market Cap |
|
National HealthCare's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.06 | 0.06 | |
| Return On Capital Employed | 0.05 | 0.05 | |
| Return On Assets | 0.05 | 0.06 | |
| Return On Equity | 0.07 | 0.07 |
Determining National HealthCare's profitability involves analyzing its financial statements and using various financial metrics to determine if National HealthCare is a good buy. For example, gross profit margin measures National HealthCare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of National HealthCare's profitability and make more informed investment decisions.
Please note, the presentation of National HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National HealthCare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of National HealthCare's management manipulating its earnings.
Evaluate National HealthCare's management efficiency
National HealthCare has Return on Asset of 0.0288 % which means that on every $100 spent on assets, it made $0.0288 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1324 %, implying that it generated $0.1324 on every 100 dollars invested. National HealthCare's management efficiency ratios could be used to measure how well National HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, National HealthCare's Return On Assets are projected to slightly decrease based on the last few years of reporting. At present, National HealthCare's Intangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.06, whereas Total Assets are forecasted to decline to about 772 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 59.47 | 62.44 | |
| Tangible Book Value Per Share | 48.02 | 50.42 | |
| Enterprise Value Over EBITDA | 10.55 | 6.89 | |
| Price Book Value Ratio | 1.56 | 1.96 | |
| Enterprise Value Multiple | 10.55 | 6.89 | |
| Price Fair Value | 1.56 | 1.96 | |
| Enterprise Value | 1.2 B | 1.3 B |
Examining the leadership quality of National HealthCare offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Dividend Yield 0.0198 | Forward Dividend Yield 0.0198 | Forward Dividend Rate 2.44 | Beta 0.428 |
Basic technical analysis of National Stock
As of the 28th of November, National HealthCare secures the Mean Deviation of 1.49, standard deviation of 2.09, and Risk Adjusted Performance of (0.01). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of National HealthCare, as well as the relationship between them.National HealthCare's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on National HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases National HealthCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
National HealthCare's Outstanding Corporate Bonds
National HealthCare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. National HealthCare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most National bonds can be classified according to their maturity, which is the date when National HealthCare has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand National HealthCare's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing National HealthCare's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 1.49 | |||
| Coefficient Of Variation | (4,728) | |||
| Standard Deviation | 2.09 | |||
| Variance | 4.36 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 11.56 | |||
| Value At Risk | (3.57) | |||
| Potential Upside | 3.12 | |||
| Skewness | 0.3801 | |||
| Kurtosis | 2.78 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.02) | |||
| Mean Deviation | 1.49 | |||
| Coefficient Of Variation | (4,728) | |||
| Standard Deviation | 2.09 | |||
| Variance | 4.36 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.03) | |||
| Maximum Drawdown | 11.56 | |||
| Value At Risk | (3.57) | |||
| Potential Upside | 3.12 | |||
| Skewness | 0.3801 | |||
| Kurtosis | 2.78 |
Consider National HealthCare's intraday indicators
National HealthCare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of National HealthCare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0216 | |||
| Daily Balance Of Power | (0.63) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 125.85 | |||
| Day Typical Price | 125.39 | |||
| Market Facilitation Index | 2.75 | |||
| Price Action Indicator | (2.24) | |||
| Period Momentum Indicator | (1.74) |
National HealthCare Corporate Filings
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
10Q | 7th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
13A | 23rd of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
National Stock media impact
Far too much social signal, news, headlines, and media speculation about National HealthCare that are available to investors today. That information is available publicly through National media outlets and privately through word of mouth or via National internal channels. However, regardless of the origin, that massive amount of National data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of National HealthCare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of National HealthCare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to National HealthCare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive National HealthCare alpha.
National HealthCare Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards National HealthCare can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
National HealthCare Corporate Executives
Elected by the shareholders, the National HealthCare's board of directors comprises two types of representatives: National HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National HealthCare's management team and ensure that shareholders' interests are well served. National HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National HealthCare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For information on how to trade National Stock refer to our How to Trade National Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National HealthCare. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.021 | Dividend Share 2.4 | Earnings Share 7.99 | Revenue Per Share 79.613 | Quarterly Revenue Growth 0.179 |
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between National HealthCare's value and its price, as these two are different measures arrived at by various means. Investors typically determine if National HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.